| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.004 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.005 |